EUVIMEDEUVIMED entdecken
Crossref

Port REMoval Outcomes (PREMO) study: Patients’ experiences with a Totally Implantable Venous Access Device: A questionnaire at device removal

Godelieve Alice Goossens iD, Thomas Douchy iD, Martine Jérôme iD, Yorick Peeters, Daphne Hompes iD, Veerle Boecxstaens

The Journal of Vascular Access · 2026

DOI: 10.1177/11297298251340461 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Vascular Access, 2026. Verfasst von Godelieve Alice Goossens und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology and Competence Centre of Nursing, University Hospitals Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Device Removal, Catheters, Indwelling, Catheterization, Central Venous, Central Venous Catheters. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: BBraun Belgium.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Totally Implantable Venous Access Devices (TIVADs) are commonly used for intravenous chemotherapy administration and may remain in place depending on the likelihood of disease relapse. Regular flushing is required to maintain patency, although there is no established consensus on the optimal interval between maintenance sessions, with some clinicians extending or omitting the procedure. While TIVADs are generally well-accepted, patients may experience physical discomfort or psychological stress, which are assessed through Patient Reported Outcomes (PROs). This study aims to evaluate the complete TIVAD experience, from insertion to removal, with a particular focus on the maintenance period, as part of the Port REMoval Outcomes (PREMO) study.

Methods

A cross-sectional survey was conducted at University Hospitals Leuven, Belgium between 2019 and 2022. Adult patients with chest TIVADs, planned for an elective removal, completed the Leuven Patient Reported Experiences at Port Removal (Leuven PREP) a self-reported, self-developed 27-item questionnaire.

Results

A total of 100 oncology patients completed the questionnaire, with a mean age of 60.9 years and a median TIVAD duration of 2093 days. Most patients reported low insertion pain (median NRS score = 2), while emotional and psychological impacts were generally minimal, with only 1% expressing constant fear. Local discomfort was mentioned, with 24.5% reporting a bump and 12% experiencing pain during needle insertion; 10% experienced frequent cosmetic issues. TIVAD maintenance adherence was limited to 70.7% following the flushing regimen, and 61.2% found extending the maintenance period valuable. The removal procedure was well-received, with 60.2% reporting it was better than expected, and overall patient satisfaction was high, with a median score of 8/10.

Conclusion

Patients expressed high satisfaction with low impact on comfort, psychological state and physical well-being. Maintenance experiences varied, highlighting the need for further investigation and a validated comprehensive questionnaire. Registration number: NCT03948958.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Device RemovalCatheters, IndwellingCatheterization, Central VenousCentral Venous CathetersAntineoplastic AgentsHumansMaleMiddle AgedFemaleCross-Sectional StudiesAgedPatient Reported Outcome MeasuresBelgiumTime FactorsAdultPatient SatisfactionTreatment OutcomeAged, 80 and over

Stichwörter der Autor:innen

TIVADcancerpatient experiencespatient-reported outcomesquestionnaire

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Surgical Oncology and Competence Centre of Nursing, University Hospitals Leuven, Leuven, Belgium.
  • Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
  • Department of Surgical Oncology, University Hospitals Leuven, Leuven, Belgium.

ORCID-Profile: Godelieve Alice Goossens, Thomas Douchy, Martine Jérôme, Daphne Hompes

Förderung

  • BBraun Belgium

Zitieren

APA

Goossens, G. A., Douchy, T., Jérôme, M., Peeters, Y., Hompes, D., & Boecxstaens, V. (2026). Port REMoval Outcomes (PREMO) study: Patients’ experiences with a Totally Implantable Venous Access Device: A questionnaire at device removal. The Journal of Vascular Access. https://doi.org/10.1177/11297298251340461

Vancouver

Goossens GA, Douchy T, Jérôme M, Peeters Y, Hompes D, Boecxstaens V. Port REMoval Outcomes (PREMO) study: Patients’ experiences with a Totally Implantable Venous Access Device: A questionnaire at device removal. The Journal of Vascular Access. 2026. doi:10.1177/11297298251340461

BibTeX
@article{Goossens2026,
  author = {Goossens, Godelieve Alice and Douchy, Thomas and Jérôme, Martine and Peeters, Yorick and Hompes, Daphne and Boecxstaens, Veerle},
  title = {Port REMoval Outcomes (PREMO) study: Patients’ experiences with a Totally Implantable Venous Access Device: A questionnaire at device removal},
  journal = {The Journal of Vascular Access},
  year = {2026},
  doi = {10.1177/11297298251340461}
}
Kostenlos starten →